{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T17:31:50Z","timestamp":1790875910735,"version":"4.1.0"},"reference-count":58,"publisher":"Public Library of Science (PLoS)","issue":"2","license":[{"start":{"date-parts":[[2024,2,15]],"date-time":"2024-02-15T00:00:00Z","timestamp":1707955200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Shanxi Province key research and development program","award":["No. 201903D311011"],"award-info":[{"award-number":["No. 201903D311011"]}]},{"name":"Shanxi Province key research and development program","award":["No. 201803D31067"],"award-info":[{"award-number":["No. 201803D31067"]}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:p>Rheumatoid arthritis (RA) and primary Sj\u00f6gren\u2019s syndrome (pSS) are the most common systemic autoimmune diseases, and they are increasingly being recognized as occurring in the same patient population. These two diseases share several clinical features and laboratory parameters, but the exact mechanism of their co-pathogenesis remains unclear. The intention of this study was to investigate the common molecular mechanisms involved in RA and pSS using integrated bioinformatic analysis. RNA-seq data for RA and pSS were picked up from the Gene Expression Omnibus (GEO) database. Co-expression genes linked with RA and pSS were recognized using weighted gene co-expression network analysis (WGCNA) and differentially expressed gene (DEG) analysis. Then, we screened two public disease\u2013gene interaction databases (GeneCards and Comparative Toxicogenomics Database) for common targets associated with RA and pSS. The DGIdb database was used to predict therapeutic drugs for RA and pSS. The Human microRNA Disease Database (HMDD) was used to screen out the common microRNAs associated with RA and pSS. Finally, a common miRNA\u2013gene network was created using Cytoscape. Four <jats:italic>hub<\/jats:italic> genes (<jats:italic>CXCL10<\/jats:italic>, <jats:italic>GZMA<\/jats:italic>, <jats:italic>ITGA4<\/jats:italic>, and <jats:italic>PSMB9<\/jats:italic>) were obtained from the intersection of common genes from WGCNA, differential gene analysis and public databases. Twenty-four drugs corresponding to hub gene targets were predicted in the DGIdb database. Among the 24 drugs, five drugs had already been reported for the treatment of RA and pSS. Other drugs, such as bortezomib, carfilzomib, oprozomib, cyclosporine and zidovudine, may be ideal drugs for the future treatment of RA patients with pSS. According to the miRNA\u2013gene network, hsa-mir-21 may play a significant role in the mechanisms shared by RA and pSS. In conclusion, we identified commom targets as potential biomarkers in RA and pSS from publicly available databases and predicted potential drugs based on the targets. A new understanding of the molecular mechanisms associated with RA and pSS is provided according to the miRNA\u2013gene network.<\/jats:p>","DOI":"10.1371\/journal.pone.0298447","type":"journal-article","created":{"date-parts":[[2024,2,15]],"date-time":"2024-02-15T18:29:15Z","timestamp":1708021755000},"page":"e0298447","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":6,"title":["Potential mechanisms and drug prediction of Rheumatoid Arthritis and primary Sj\u00f6gren\u2019s Syndrome: A public databases-based study"],"prefix":"10.1371","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-8074-9711","authenticated-orcid":true,"given":"Li","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi-chao","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gao-xiang","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fu-rong","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei-Feng","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7796-6899","authenticated-orcid":true,"given":"Qi","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2024,2,15]]},"reference":[{"issue":"9285","key":"pone.0298447.ref001","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/S0140-6736(01)06075-5","article-title":"Rheumatoid arthritis","volume":"358","author":"DM Lee","year":"2001","journal-title":"Lancet"},{"issue":"2","key":"pone.0298447.ref002","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0049-0172(99)80039-0","article-title":"Neuroendocrine, immunologic, and microvascular systems interactions in rheumatoid arthritis: physiopathogenetic and therapeutic perspectives","volume":"29","author":"AT Masi","year":"1999","journal-title":"Semin Arthritis Rheum"},{"issue":"9482","key":"pone.0298447.ref003","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S0140-6736(05)66990-5","article-title":"Sjogren\u2019s syndrome","volume":"366","author":"RI Fox","year":"2005","journal-title":"Lancet"},{"key":"pone.0298447.ref004","doi-asserted-by":"crossref","first-page":"e3821","DOI":"10.1136\/bmj.e3821","article-title":"Primary Sjogren syndrome","volume":"344","author":"M Ramos-Casals","year":"2012","journal-title":"BMJ"},{"issue":"6","key":"pone.0298447.ref005","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1093\/rheumatology\/keaa009","article-title":"Equal rights in autoimmunity: is Sjogren\u2019s syndrome ever \u2019secondary\u2019?","volume":"59","author":"F Kollert","year":"2020","journal-title":"Rheumatology (Oxford)"},{"issue":"5","key":"pone.0298447.ref006","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1093\/rheumatology\/key330","article-title":"Genetics and epigenetics in primary Sjogren\u2019s syndrome","volume":"60","author":"J Imgenberg-Kreuz","year":"2021","journal-title":"Rheumatology (Oxford)"},{"issue":"2","key":"pone.0298447.ref007","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1080\/03009742.2017.1324909","article-title":"Systematic review and meta-analysis of the epidemiology of polyautoimmunity in Sjogren\u2019s syndrome (secondary Sjogren\u2019s syndrome) focusing on autoimmune rheumatic diseases","volume":"47","author":"H Alani","year":"2018","journal-title":"Scand J Rheumatol"},{"issue":"7","key":"pone.0298447.ref008","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1093\/rheumatology\/kew023","article-title":"Previous diagnosis of Sj\u00f6gren\u2019s Syndrome as rheumatoid arthritis or systemic lupus erythematosus","volume":"55","author":"A Rasmussen","year":"2016","journal-title":"Rheumatology"},{"key":"pone.0298447.ref009","first-page":"8","article-title":"Primary Sjogren\u2019s syndrome: diagnostic criteria, clinical features, and disease activity","volume":"50","author":"R Manthorpe","year":"1997","journal-title":"J Rheumatol Suppl"},{"issue":"2","key":"pone.0298447.ref010","article-title":"NLRP3 Gene Polymorphisms in Rheumatoid Arthritis and Primary Sjogren\u2019s Syndrome Patients","volume":"13","author":"RN Li","year":"2023","journal-title":"Diagnostics (Basel)"},{"issue":"2","key":"pone.0298447.ref011","doi-asserted-by":"crossref","first-page":"102735","DOI":"10.1016\/j.autrev.2020.102735","article-title":"Beyond the joints, the extra-articular manifestations in rheumatoid arthritis","volume":"20","author":"A Conforti","year":"2021","journal-title":"Autoimmun Rev"},{"key":"pone.0298447.ref012","doi-asserted-by":"crossref","first-page":"3851","DOI":"10.1016\/j.csbj.2022.07.018","article-title":"Gene expression data analysis using Hellinger correlation in weighted gene co-expression networks (WGCNA)","volume":"20","author":"T Zhang","year":"2022","journal-title":"Computational and structural biotechnology journal"},{"issue":"1","key":"pone.0298447.ref013","doi-asserted-by":"crossref","first-page":"7950","DOI":"10.1080\/21655979.2021.1984004","article-title":"Identification of important genes related to ferroptosis and hypoxia in acute myocardial infarction based on WGCNA","volume":"12","author":"K Liu","year":"2021","journal-title":"Bioengineered"},{"key":"pone.0298447.ref014","doi-asserted-by":"crossref","first-page":"904312","DOI":"10.3389\/fendo.2022.904312","article-title":"Bioinformatics Analysis Identifies Potential Ferroptosis Key Gene in Type 2 Diabetic Islet Dysfunction","volume":"13","author":"H Ye","year":"2022","journal-title":"Frontiers in endocrinology"},{"issue":"8","key":"pone.0298447.ref015","doi-asserted-by":"crossref","first-page":"e18869","DOI":"10.1016\/j.heliyon.2023.e18869","article-title":"Introducing novel key genes and transcription factors associated with rectal cancer response to chemoradiation through co-expression network analysis","volume":"9","author":"S Afshar","year":"2023","journal-title":"Heliyon"},{"key":"pone.0298447.ref016","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1186\/1471-2105-9-559","article-title":"WGCNA: an R package for weighted correlation network analysis","volume":"9","author":"P Langfelder","year":"2008","journal-title":"BMC Bioinformatics"},{"issue":"D1","key":"pone.0298447.ref017","doi-asserted-by":"crossref","first-page":"D1138","DOI":"10.1093\/nar\/gkaa891","article-title":"Comparative Toxicogenomics Database (CTD): update 2021","volume":"49","author":"AP Davis","year":"2021","journal-title":"Nucleic Acids Res"},{"key":"pone.0298447.ref018","doi-asserted-by":"crossref","first-page":"baq020","DOI":"10.1093\/database\/baq020","article-title":"GeneCards Version 3: the human gene integrator","volume":"2010","author":"M Safran","year":"2010","journal-title":"Database (Oxford)"},{"issue":"7","key":"pone.0298447.ref019","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.1093\/nar\/gkv007","article-title":"limma powers differential expression analyses for RNA-sequencing and microarray studies","volume":"43","author":"ME Ritchie","year":"2015","journal-title":"Nucleic Acids Res"},{"issue":"5","key":"pone.0298447.ref020","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1089\/omi.2011.0118","article-title":"clusterProfiler: an R package for comparing biological themes among gene clusters","volume":"16","author":"G Yu","year":"2012","journal-title":"OMICS"},{"issue":"17","key":"pone.0298447.ref021","doi-asserted-by":"crossref","first-page":"2912","DOI":"10.1093\/bioinformatics\/btv300","article-title":"GOplot: an R package for visually combining expression data with functional analysis","volume":"31","author":"W Walter","year":"2015","journal-title":"Bioinformatics"},{"issue":"D1","key":"pone.0298447.ref022","doi-asserted-by":"crossref","first-page":"D1068","DOI":"10.1093\/nar\/gkx1143","article-title":"DGIdb 3.0: a redesign and expansion of the drug-gene interaction database","volume":"46","author":"KC Cotto","year":"2018","journal-title":"Nucleic Acids Res"},{"issue":"D1","key":"pone.0298447.ref023","doi-asserted-by":"crossref","first-page":"D1144","DOI":"10.1093\/nar\/gkaa1084","article-title":"Integration of the Drug-Gene Interaction Database (DGIdb 4.0) with open crowdsource efforts","volume":"49","author":"SL Freshour","year":"2021","journal-title":"Nucleic Acids Res"},{"issue":"10","key":"pone.0298447.ref024","doi-asserted-by":"crossref","first-page":"e3420","DOI":"10.1371\/journal.pone.0003420","article-title":"An analysis of human microRNA and disease associations","volume":"3","author":"M Lu","year":"2008","journal-title":"PLoS One"},{"issue":"D1","key":"pone.0298447.ref025","doi-asserted-by":"crossref","first-page":"D222","DOI":"10.1093\/nar\/gkab1079","article-title":"miRTarBase update 2022: an informative resource for experimentally validated miRNA-target interactions","volume":"50","author":"HY Huang","year":"2022","journal-title":"Nucleic Acids Res"},{"issue":"4","key":"pone.0298447.ref026","first-page":"286","article-title":"Extra-articular Manifestations in Rheumatoid Arthritis","volume":"5","author":"M Cojocaru","year":"2010","journal-title":"Maedica (Bucur)"},{"issue":"8","key":"pone.0298447.ref027","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1136\/ard.62.8.722","article-title":"Extra-articular disease manifestations in rheumatoid arthritis: incidence trends and risk factors over 46 years","volume":"62","author":"C Turesson","year":"2003","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"pone.0298447.ref028","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/j.berh.2007.05.007","article-title":"Extra-articular manifestations and complications of rheumatoid arthritis","volume":"21","author":"A Young","year":"2007","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"6","key":"pone.0298447.ref029","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/PL00006853","article-title":"Extra-articular manifestations in 587 Italian patients with rheumatoid arthritis","volume":"19","author":"MA Cimmino","year":"2000","journal-title":"Rheumatol Int"},{"issue":"7","key":"pone.0298447.ref030","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1136\/ard.58.7.415","article-title":"Sicca symptoms, saliva and tear production, and disease variables in 636 patients with rheumatoid arthritis","volume":"58","author":"T Uhlig","year":"1999","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"pone.0298447.ref031","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1080\/25785826.2020.1729597","article-title":"Dry eye in rheumatoid arthritis: relation to disease activity","volume":"43","author":"NM Abd-Allah","year":"2020","journal-title":"Immunol Med"},{"issue":"6","key":"pone.0298447.ref032","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1136\/ard.2005.041186","article-title":"Lymphoma and other malignancies in primary Sjogren\u2019s syndrome: a cohort study on cancer incidence and lymphoma predictors","volume":"65","author":"E Theander","year":"2006","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"pone.0298447.ref033","first-page":"143","article-title":"Outcome measures for Sjogren\u2019s syndrome, April 10\u201311, 2003, Bethesda, Maryland","volume":"32","author":"SR Pillemer","year":"2005","journal-title":"USA. J Rheumatol"},{"issue":"6","key":"pone.0298447.ref034","doi-asserted-by":"crossref","first-page":"888","DOI":"10.7326\/0003-4819-89-6-888","article-title":"Increased risk of lymphoma in sicca syndrome","volume":"89","author":"SS Kassan","year":"1978","journal-title":"Ann Intern Med"},{"issue":"1","key":"pone.0298447.ref035","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s13577-021-00641-w","article-title":"Identification of diagnostic signatures in ulcerative colitis patients via bioinformatic analysis integrated with machine learning","volume":"35","author":"J Lu","year":"2022","journal-title":"Hum Cell"},{"issue":"1","key":"pone.0298447.ref036","doi-asserted-by":"crossref","first-page":"2214","DOI":"10.1080\/21655979.2021.1933743","article-title":"Identification of TYR, TYRP1, DCT and LARP7 as related biomarkers and immune infiltration characteristics of vitiligo via comprehensive strategies","volume":"12","author":"J Zhang","year":"2021","journal-title":"Bioengineered"},{"key":"pone.0298447.ref037","doi-asserted-by":"crossref","first-page":"722803","DOI":"10.3389\/fgene.2021.722803","article-title":"Identification of Potential Biomarkers for Psoriasis by DNA Methylation and Gene Expression Datasets","volume":"12","author":"Y Liu","year":"2021","journal-title":"Front Genet"},{"issue":"5","key":"pone.0298447.ref038","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.autrev.2008.12.002","article-title":"CXCL10 and autoimmune diseases","volume":"8","author":"EY Lee","year":"2009","journal-title":"Autoimmun Rev"},{"issue":"1","key":"pone.0298447.ref039","doi-asserted-by":"crossref","first-page":"1588538","DOI":"10.1080\/20013078.2019.1588538","article-title":"Extracellular vesicles derived from natural killer cells use multiple cytotoxic proteins and killing mechanisms to target cancer cells","volume":"8","author":"CH Wu","year":"2019","journal-title":"J Extracell Vesicles"},{"issue":"2","key":"pone.0298447.ref040","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1002\/art.39857","article-title":"Granzyme A Contributes to Inflammatory Arthritis in Mice Through Stimulation of Osteoclastogenesis","volume":"69","author":"L Santiago","year":"2017","journal-title":"Arthritis Rheumatol"},{"issue":"6","key":"pone.0298447.ref041","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1038\/leu.2011.369","article-title":"The CD49d\/CD29 complex is physically and functionally associated with CD38 in B-cell chronic lymphocytic leukemia cells","volume":"26","author":"A Zucchetto","year":"2012","journal-title":"Leukemia"},{"issue":"4","key":"pone.0298447.ref042","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.ajhg.2014.02.013","article-title":"Fine mapping seronegative and seropositive rheumatoid arthritis to shared and distinct HLA alleles by adjusting for the effects of heterogeneity","volume":"94","author":"B Han","year":"2014","journal-title":"Am J Hum Genet"},{"issue":"1","key":"pone.0298447.ref043","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1111\/bjh.13788","article-title":"CD49d (ITGA4) expression is a predictor of time to first treatment in patients with chronic lymphocytic leukaemia and mutated IGHV status","volume":"172","author":"T Baumann","year":"2016","journal-title":"Br J Haematol"},{"issue":"3","key":"pone.0298447.ref044","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/35056572","article-title":"Antigen processing by the proteasome","volume":"2","author":"PM Kloetzel","year":"2001","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"5","key":"pone.0298447.ref045","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1111\/bjd.14385","article-title":"The role of PSMB9 upregulated by interferon signature in the pathophysiology of cutaneous lesions of dermatomyositis and systemic lupus erythematosus","volume":"174","author":"K Nakamura","year":"2016","journal-title":"Br J Dermatol"},{"issue":"6","key":"pone.0298447.ref046","doi-asserted-by":"crossref","first-page":"406","DOI":"10.7326\/0003-4819-146-6-200703200-00005","article-title":"Comparison of treatment strategies in early rheumatoid arthritis: a randomized trial","volume":"146","author":"YP Goekoop-Ruiterman","year":"2007","journal-title":"Ann Intern Med"},{"issue":"1","key":"pone.0298447.ref047","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1097\/RHU.0000000000000210","article-title":"Refractory primary Sjogren syndrome successfully treated with bortezomib","volume":"21","author":"J Jakez-Ocampo","year":"2015","journal-title":"J Clin Rheumatol"},{"issue":"52","key":"pone.0298447.ref048","doi-asserted-by":"crossref","first-page":"e5760","DOI":"10.1097\/MD.0000000000005760","article-title":"Bortezomib followed by autologous stem cell transplantation in a patient with rheumatoid arthritis: A case report and review of the literature","volume":"95","author":"J Liu","year":"2016","journal-title":"Medicine (Baltimore)"},{"issue":"1","key":"pone.0298447.ref049","first-page":"28","article-title":"Tetracyclines inhibit human synovial collagenase in vivo and in vitro","volume":"14","author":"RA Greenwald","year":"1987","journal-title":"J Rheumatol"},{"issue":"5","key":"pone.0298447.ref050","doi-asserted-by":"crossref","first-page":"405","DOI":"10.2165\/00002018-200022050-00007","article-title":"Benefits and risks of minocycline in rheumatoid arthritis","volume":"22","author":"P Langevitz","year":"2000","journal-title":"Drug Saf"},{"issue":"6","key":"pone.0298447.ref051","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1007\/s13346-019-00650-1","article-title":"Recent advances in cyclosporine drug delivery: challenges and opportunities","volume":"9","author":"D Patel","year":"2019","journal-title":"Drug Deliv Transl Res"},{"issue":"4","key":"pone.0298447.ref052","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/s40266-021-00838-6","article-title":"Therapeutic Recommendations for the Management of Older Adult Patients with Sjogren\u2019s Syndrome","volume":"38","author":"S Retamozo","year":"2021","journal-title":"Drugs Aging"},{"issue":"20","key":"pone.0298447.ref053","doi-asserted-by":"crossref","first-page":"7096","DOI":"10.1073\/pnas.82.20.7096","article-title":"3\u2019-Azido-3\u2019-deoxythymidine (BW A509U): an antiviral agent that inhibits the infectivity and cytopathic effect of human T-lymphotropic virus type III\/lymphadenopathy-associated virus in vitro","volume":"82","author":"H Mitsuya","year":"1985","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"9","key":"pone.0298447.ref054","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1093\/rheumatology\/38.9.814","article-title":"Zidovudine in primary Sjogren\u2019s syndrome","volume":"38","author":"SD Steinfeld","year":"1999","journal-title":"Rheumatology (Oxford)"},{"issue":"11","key":"pone.0298447.ref055","doi-asserted-by":"crossref","first-page":"e0260327","DOI":"10.1371\/journal.pone.0260327","article-title":"Hsa-miR-21-3p associates with breast cancer patient survival and targets genes in tumor suppressive pathways","volume":"16","author":"A Amirfallah","year":"2021","journal-title":"PLoS One"},{"issue":"12","key":"pone.0298447.ref056","doi-asserted-by":"crossref","first-page":"4075","DOI":"10.31557\/APJCP.2021.22.12.4075","article-title":"The Role of hsa-miR-21 and Its Target Genes Involved in Nasopharyngeal Carcinoma","volume":"22","author":"TD Lao","year":"2021","journal-title":"Asian Pac J Cancer Prev"},{"issue":"9","key":"pone.0298447.ref057","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.7150\/ijms.73404","article-title":"Comprehensive Analysis of Transcriptional Expression of hsa-mir-21 Predicted Target Genes and Immune Characteristics in Kidney Renal Clear Cell Carcinoma","volume":"19","author":"DM Xu","year":"2022","journal-title":"Int J Med Sci"},{"issue":"10","key":"pone.0298447.ref058","doi-asserted-by":"crossref","DOI":"10.3390\/cells10102547","article-title":"miR-21-3p\/IL-22 Axes Are Major Drivers of Psoriasis Pathogenesis by Modulating Keratinocytes Proliferation-Survival Balance and Inflammatory Response","volume":"10","author":"F Abdallah","year":"2021","journal-title":"Cells"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0298447","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,15]],"date-time":"2024-02-15T18:29:56Z","timestamp":1708021796000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0298447"}},"subtitle":[],"editor":[{"given":"Gurudeeban","family":"Selvaraj","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2024,2,15]]},"references-count":58,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2024,2,15]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0298447","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,15]]}}}